Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

An Introduction to the Bootstrap

Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468

An Introduction to the Bootstrap

Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602

Cox’s regression model for counting processes: A large sample study

Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419

Isolation of rare circulating tumour cells in cancer patients by microchip technology

Nagrath, S., Sequist, L. V. D., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S. R., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,595

Cell-free nucleic acids as biomarkers in cancer patients

Schwarzenbach, H., Hoon, D. S. �., & Pantel, K. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3066 · Cited by 2,897

Liquid biopsies in cancer

Yin, H., Zhang, M., Zhang, Y., Zhang, X., Zhang, B., & Zhang, B. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00257-8 · Cited by 41

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy

Lang, J. E., Wecsler, J. S., Press, M. F., & Tripathy, D. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23732 · Cited by 37

Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA.

Alix‐Panabières, C., & Pantel, K. (2013) · PubMed Central · doi:10.3978/j.issn.2305-5839.2013.06.02 · Cited by 37

A One-Page Summary Report of Genome Sequencing for the Healthy Adult

Vassy, J. L., McLaughlin, H. L., MacRae, C. A., Seidman, C. E., Lautenbach, D. M., Krier, J. B., Lane, W. J., Kohane, I. S., Murray, M. F., McGuire, A. L., et al. (2015) · Public Health Genomics · doi:10.1159/000370102 · Cited by 37

Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases

Charles, J. P., Fuchs, J., Hefter, M., Vischedyk, J. B., Kleint, M., Vogiatzi, F., Schäfer, J., Nist, A., Timofeev, O. N., Wanzel, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4981 · Cited by 36

Global Measures of Peripheral Blood-Derived DNA Methylation as a Risk Factor in the Development of Mature B-Cell Neoplasms

Doo, N. W., Makalic, E., Joo, J. E., Vajdic, C. M., Schmidt, D. F., Wong, E. M., Jung, C., Severi, G., Park, D. J., Chung, J., et al. (2015) · Epigenomics · doi:10.2217/epi.15.97 · Cited by 37

Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer

Hrebien, S., O’Leary, B., Beaney, M., Schiavon, G., Fribbens, C. V., Bhambra, A., Johnson, R., García-Murillas, I., & Turner, N. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165023 · Cited by 40

Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer

Amin, S., & Bathe, O. F. (2016) · BMC Cancer · doi:10.1186/s12885-016-2886-9 · Cited by 37

Selection of a Novel Aptamer Against Vitronectin Using Capillary Electrophoresis and Next Generation Sequencing

Stuart, C. H., Riley, K. R., Boyacıoğlu, O., Herpai, D., Debinski, W., Qasem, S. A., Marini, F. C., Colyer, C. L., & Gmeiner, W. H. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.91 · Cited by 37

Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer

von Bubnoff, N. C. C. (2017) · Oncology Research and Treatment · doi:10.1159/000478864 · Cited by 38

Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients

Provencio, M., Torrente, M., Calvo, V., Pérez-Callejo, D., Gutiérrez, L., Franco, F., Pérez-Barrios, C., Barquín, M., Royuela, A., Garcia‐García, F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22470 · Cited by 37

Targeted mutation detection in breast cancer using MammaSeq™

Smith, N. G., Gyanchandani, R., Shah, O. S., Gurda, G. T., Lucas, P. C., Hartmaier, R. J., Brufsky, A., Puhalla, S., Bahreini, A., Kota, K. J., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1102-7 · Cited by 36

The Gasdermin E Gene Has Potential as a Pan-Cancer Biomarker, While Discriminating between Different Tumor Types

Ibrahim, J., de Beeck, K. O., Fransén, E., Peeters, M., & Camp, G. V. (2019) · Cancers · doi:10.3390/cancers11111810 · Cited by 37

Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer: A Pilot Study

Li, X., Lu, J., Zhang, L., Luo, Y., Zhao, Z., & Li, M. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.11.007 · Cited by 40

Concentration of cell-free DNA in different tumor types

Bryzgunova, O. E., Konoshenko, M. Y., & Laktionov, P. P. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1860021 · Cited by 37

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine

Παναγοπούλου, Μ., Esteller, M., & Chatzaki, Ε. (2021) · Cancers · doi:10.3390/cancers13040728 · Cited by 37

Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patientPreprint

Welter, L. M., Xu, L., McKinley, D., Dago, A. E., Prabakar, R. K., Restrepo-Vassalli, S., Xu, K., Rodrı́guez-Lee, M., Kolatkar, A. R., Nevarez, R., et al. (2020) · Molecular Case Studies · doi:10.1101/mcs.a005819 · Cited by 37

Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsy

Kinane, D. F., Gabert, J., Xynopoulos, G., & Guzeldemir-Akcakanat, E. (2024) · Periodontology 2000 · doi:10.1111/prd.12567 · Cited by 38

Liquid biopsy

Gingras, I., Salgado, R., & Ignatiadis, M. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000223 · Cited by 38

Biased estimates of clonal evolution and subclonal heterogeneity can arise from PCR duplicates in deep sequencing experiments

Smith, E. N., Jepsen, K., Khosroheidari, M., Rassenti, L. Z., D’Antonio, M., Ghia, E. M., Carson, D. A., Jamieson, C. H. M., Kipps, T. J., & Frazer, K. A. (2014) · Genome biology · doi:10.1186/preaccept-1251182501124451 · Cited by 35

Computer Aided Theragnosis Using Quantitative Ultrasound Spectroscopy and Maximum Mean Discrepancy in Locally Advanced Breast Cancer

Gangeh, M. J., Tadayyon, H., Sannachi, L., Naini, A. S., Tran, W. T., & Czarnota, G. J. (2015) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2015.2495246 · Cited by 36

Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent

Xie, B., Tomaszewski, M. R., Neves, A., R�os, S., Hu, D., McGuire, S., Mullins, S., Tice, D. A., Sainson, R. C. A., Bohndiek, S. E., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1029 · Cited by 36

DNA terminal structure-mediated enzymatic reaction for ultra-sensitive discrimination of single nucleotide variations in circulating cell-free DNA

Wu, T., Chen, W., Yang, W., Tan, H., Wang, J., Xiao, X., Li, M., & Zhao, M. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1218 · Cited by 37

Circulating Tumor Cells and Circulating Tumor DNA

Lianidou, E. S., & Hoon, D. S. �. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-816061-9.00009-6 · Cited by 36

Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment

Suppan, C., Brčić, I., Tiran, V., MUELLER, H. ‐., Posch, F., Auer, M., Ercan, E., Ulz, P., Côté, R. J., Datar, R. H., et al. (2019) · Cancers · doi:10.3390/cancers11081171 · Cited by 36

Liquid Biopsy: Application in Early Diagnosis and Monitoring of Cancer

Feng, J., Li, B., Ying, J., Pan, W., Liu, C., Luo, T., Lin, H., & Zheng, L. (2020) · Small Structures · doi:10.1002/sstr.202000063 · Cited by 37

Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients

Keup, C., Suryaprakash, V., Storbeck, M., Hoffmann, O., Kimmig, R., & Kasimir‐Bauer, S. (2021) · Cells · doi:10.3390/cells10020212 · Cited by 39

What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA

Danesi, R., Lo, Y. M. D., Oellerich, M., Beck, J., Galbiati, S., Re, M. D., Lianidou, E. S., Neumaier, M., & van Schaik, R. H. N. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.05.033 · Cited by 36

Clinical implementation and current advancement of blood liquid biopsy in cancer

Watanabe, K., Nakamura, Y., & Low, S. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00939-5 · Cited by 37

Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities

Liebs, S., Eder, T., Klauschen, F., Schütte, M., Yaspo, M., Keilholz, U., Tinhofer, I., Kidess, E., & Braunholz, D. (2021) · Oncogene · doi:10.1038/s41388-021-01928-w · Cited by 38

Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer

Yang, F., Tang, J., Zhao, Z., Zhao, C., & Xiang, Y. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00860-8 · Cited by 38

An Exposure to the Oxidized DNA Enhances Both Instability of Genome and Survival in Cancer Cells

Kostyuk, S. V., Konkova, M. S., Ershova, E. S., Alekseeva, A. Y., Smirnova, T. D., Stukalov, S. V., Kozhina, E. A., Шилова, Н. В., Zolotukhina, T. V., Маркова, Ж. Г., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077469 · Cited by 37

Words Matter: Distinguishing "Personalized Medicine" and "Biologically Personalized Therapeutics"

Cherny, N. I., de Vries, E. G. E., Emanuel, L., Fallowfield, L. J., Francis, P. A., Gabizon, A., Piccart, M. J., Sidransky, D., Soussan‐Gutman, L., & Tziraki, C. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju321 · Cited by 40

A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease

Ferreira, E. N., Barros, B. D. D. F., de Souza, J. E., de Almeida, R. V. B., Torrezan, G. T., Garcia, S., Krepischi, A. C. V., de Mello, C. A. L., da Cunha, I. W., Pinto, C. A. L., et al. (2016) · Human Genomics · doi:10.1186/s40246-016-0092-0 · Cited by 36

Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism

Zaccagna, F., Grist, J. T., Deen, S. S., Woitek, R., Lechermann, L. M., McLean, M. A., Basu, B., & Gallagher, F. A. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170688 · Cited by 36

Circulating tumor cells in colorectal cancer in the era of precision medicine

Hu, M., Wang, Z., Wu, Z., Ding, P., Pei, R., Wang, Q., & Xing, C. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02162-3 · Cited by 38

Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice

Li, M., Hu, S. C., Lei, H.-H., Meng, Y., Xu, L., Hou, W.-K., Huang, X.-J., Xiao, B.-W., Yu, T., Zhang, X., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54706-z · Cited by 38

Ex vivo and in vivo capture and deactivation of circulating tumor cells by dual-antibody-coated nanomaterials

Xie, J., Gao, Y., Zhao, R., Sinko, P. J., Gu, S., Wang, J., Li, Y., Lu, Y., Yu, S., Wang, L., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.036 · Cited by 35

Translational utility of next-generation sequencing

Ong, F. S.-C., Lin, J., Das, K., Grosu, D. S., & Fan, J. (2013) · Genomics · doi:10.1016/j.ygeno.2013.04.012 · Cited by 35

Targeted Deep DNA Methylation Analysis of Circulating Cell-free DNA in Plasma Using Massively Parallel Semiconductor Sequencing

Vaca‐Paniagua, F., Oliver, J., da Costa, A. N., Merle, P., McKay, J., Herceg, Z., & Holmila, R. J. (2015) · Epigenomics · doi:10.2217/epi.14.94 · Cited by 35

SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients

Stadler, J. T., Eder, J., Pratscher, B., Brandt, S., Schneller, D., ­Müllegger, R., Vogl, C., Trautinger, F., Brem, G., & Burgstaller, J. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142273 · Cited by 35

Serial profiling of circulating tumor DNA for optimization of anti‐VEGF chemotherapy in metastatic colorectal cancer patients

Yamauchi, M., Urabe, Y., Ono, A., Miki, D., Ochi, H., & Chayama, K. (2017) · International Journal of Cancer · doi:10.1002/ijc.31154 · Cited by 35

The Omics Revolution Continues: The Maturation of High-Throughput Biological Data Sources

Mathé, E. A., Hays, J. L., Stover, D. G., & Chen, J. L. (2018) · Yearbook of Medical Informatics · doi:10.1055/s-0038-1667085 · Cited by 33

Using plasma cell‐free DNA to monitor the chemoradiotherapy course of cervical cancer

Tian, J., Geng, Y., Lv, D., Li, P., Córdova‐Delgado, M., Liao, Y., Tian, X., Zhang, X., Zhang, Q., Zou, K., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32295 · Cited by 35

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Remón, J., García‐Campelo, R., de Álava, E., Vera, R., Rodríguez‐­Peralto, J. L., Rodríguez-Lescure, Á., Bellosillo, B., Garrido, P., Rojo, F., & Álvarez-Alegret, R. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02211-x · Cited by 37

Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis

Jayaram, A., Wingate, A., Wetterskog, D., Conteduca, V., Khalaf, D. J., Sharabiani, M. T. A., Calabrò, F., Barwell, L., Feyerabend, S., Grande, E., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00123 · Cited by 35

Circulating tumor DNA in colorectal cancer: opportunities and challenges.

Bi, F., Wang, Q., Dong, Q., Wang, Y., Zhang, L., & Zhang, J. (2020) · PubMed Central · Cited by 35

Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer

Vafaei, S., Roudi, R., Madjd, Z., Aref, A. R., & Ebrahimi, M. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01389-3 · Cited by 35

The Diagnostic Accuracy of Liquid Biopsy in EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis of 40 Studies

Wang, N., Zhang, X., Wang, F., Zhang, M., Sun, B., Yin, W., Deng, S., Wan, Y., & Lü, W. (2020) · SLAS TECHNOLOGY · doi:10.1177/2472630320939565 · Cited by 38

Exosomal lncRNA PCAT1 Promotes Tumor Circulating Cell-Mediated Colorectal Cancer Liver Metastasis by Regulating the Activity of the miR-329-3p/Netrin-1-CD146 Complex

Fang, X., Xu, Y., Li, K., Liu, P., Zhang, H., Jiang, Y., Tang, J., & Li, Y. (2022) · Journal of Immunology Research · doi:10.1155/2022/9916228 · Cited by 35

Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors

Openshaw, M. R., Harvey, R. A., Sebire, N. J., Kaur, B. S., Sarwar, N., Seckl, M. J., & Fisher, R. A. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.022 · Cited by 35

Established and Novel Prognostic Biomarkers in Multiple Myeloma

Bustoros, M. W., Mouhieddine, T. H., Detappe, A., & Ghobrial, I. M. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175175 · Cited by 35

Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancerPreprint

Butler, T. M., Boniface, C. T., Johnson-Camacho, K., Tabatabaei, S., Melendez, D., Kelley, T., Gray, J. W., Corless, C. L., & Spellman, P. T. (2019) · Molecular Case Studies · doi:10.1101/mcs.a003772 · Cited by 34

Plasma ctDNA as a Treatment Response Biomarker in Metastatic Cancers: Evaluation by the RECIST Working Group

Wyatt, A. W., Litière, S., Bidard, F., Cabel, L., Dyrskjøt, L., Karlovich, C., Pantel, K., Petrie, J., Philip, R., Andrews, H. S., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1883 · Cited by 34

Advancing precision and personalized breast cancer treatment through multi-omics technologies

Zhang, C. (2024) · American Journal of Cancer Research · doi:10.62347/mwnz5609 · Cited by 34

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

Borad, M. J., Egan, J. B., Condjella, R. M., Liang, W. S., Fonseca, R., Ritacca, N. R., McCullough, A. E., Barrett, M. T., Hunt, K. S., Champion, M. D., et al. (2016) · Scientific Reports · doi:10.1038/s41598-016-0021-4 · Cited by 34

Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages

Yang, M., Topaloĝlu, Ü., Petty, W. J., Pagni, M., Foley, K. L., Grant, S. C., Robinson, M., Bitting, R. L., Thomas, A., Alistar, A. T., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0468-1 · Cited by 34

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients

Long-Mira, É., Ilié, M., Chamorey, E., Leduff-Blanc, F., Montaudié, H., Tanga, V., Allégra, M., Lespinet‐Fabre, V., Bordone, O., Bonnetaud, C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26343 · Cited by 34

Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies

Zorofchian, S., Iqbal, F., Rao, M., Aung, P. P., Esquenazi, Y., & Ballester, L. Y. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205414 · Cited by 33

Cancer Treatment in the Genomic Era

Doherty, G. J., Petruzzelli, M., Beddowes, E. J., Ahmad, S. S., Caldas, C., & Gilbertson, R. J. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-011840 · Cited by 36

Progress towards molecular-based management of childhood Langerhans cell histiocytosis

Héritier, S., Emile, J., Hélias‐Rodzewicz, Z., & Donadieu, J. (2019) · Archives de Pédiatrie · doi:10.1016/j.arcped.2019.05.015 · Cited by 35

Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer

Zhang, J., Dai, D., Tian, J., Li, L., Bai, J., Xu, Y., Wang, Z., & Tang, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657483 · Cited by 34

Lung cancer induced by Benzo(A)Pyrene: ChemoProtective effect of sinapic acid in swiss albino mice

Hu, X., Geetha, R. V., Surapaneni, K. M., Veeraraghavan, V. P., Chinnathambi, A., Alahmadi, T. A., Manikandan, V., & Manokaran, K. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.08.001 · Cited by 34

Socio-economic burden of disease: Survivorship costs for bladder cancer

Michaeli, J. C., Boch, T., Albers, S., Michaeli, T., & Michaeli, D. T. (2022) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2022.100326 · Cited by 36

Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer

Li, S., Xin, K., Pan, S., Wang, Y., Zheng, J., Li, Z., Liu, X., Liu, B., Xu, Z., & Chen, X. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00442-z · Cited by 34

FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor

Färkkilä, A., McConechy, M. K., Yang, W., Talhouk, A., Ng, Y., Lum, A. M., Morin, R. D., Bushell, K. R., Riska, A., McAlpine, J. N., et al. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.08.005 · Cited by 34

Liquid Biopsies: Emerging role and clinical applications in solid tumours

Sisodiya, S., Kasherwal, V., Khan, A., Roy, B., Goel, A., Kumar, S., Arif, N., Tanwar, P., & Hussain, S. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101716 · Cited by 36

A Pilot Study Assessing the Incidence and Clinical Significance of Circulating Tumor Cells in Esophagogastric Cancers

Sclafani, F., Smyth, E. C., Cunningham, D., Chau, I., Turner, A., & Watkins, D. J. (2013) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2013.11.003 · Cited by 33

Activation of endogenous human stem cell-associated retroviruses (SCARs) and therapy-resistant phenotypes of malignant tumors

Glinsky, G. V. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.014 · Cited by 31

Analysis of Circulating Tumor Cells in Breast Cancer

Eroglu, Z., Fielder, O., & Somlo, G. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0118 · Cited by 33

Multiplex Real-Time PCR Assays that Measure the Abundance of Extremely Rare Mutations Associated with Cancer

Vargas, D. Y., Kramer, F. R., Tyagi, S., & Marras, S. A. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156546 · Cited by 32

Capturing tumor heterogeneity and clonal evolution in solid cancers using circulating tumor DNA analysis

Perdigones, N., & Murtaza, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.003 · Cited by 33

HPV circulating tumor DNA to monitor the efficacy of anti‐PD‐1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report

Cabel, L., Bidard, F., Servois, V., Cacheux, W., Mariani, P., Romano, E., Minsat, M., Bièche, I., Farkhondeh, F., Jeannot, E., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30863 · Cited by 33

A Novel Method to Detect Early Colorectal Cancer Based on Chromosome Copy Number Variation in Plasma

Xu, J., Kang, Q., Ma, X.-Y., Pan, Y., Yang, L., Jin, P., Wang, X., Li, C., Chen, X., Wu, C., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487571 · Cited by 31

Circulating tumour-derived DNA in metastatic soft tissue sarcoma

Eastley, N. C., Ottolini, B., Neumann, R., Luo, J., Hastings, R. K., Khan, I., Moore, D. A., Esler, C. P., Shaw, J., Royle, N. J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24278 · Cited by 33

Cell-Free Plasma DNA for Disease Stratification and Prognosis in Head and Neck Cancer

Schirmer, M., Beck, J., Leu, M., Oellerich, M., Rave‐Fränk, M., Walson, P. D., Schütz, E., & Canis, M. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.285668 · Cited by 33

Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer

McKenna, M. T., Weis, J. A., Brock, A., Quaranta, V., & Yankeelov, T. E. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.03.009 · Cited by 33

The potential of ctDNA analysis in breast cancer

Tzanikou, E., & Lianidou, E. S. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1670615 · Cited by 33

Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction

Chang, S., Liew, P., Ansar, M., Lin, S.-Y., Wang, S.-C., Hung, C., Chen, J.-Y., Jain, S., & Lin, R.-K. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00855-z · Cited by 33

Cancer of the Breast

Henry, N. L., Shah, P. D., Haider, I., Freer, P. E., Jagsi, R., & Sabel, M. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00088-8 · Cited by 37

Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience

Mao, L., Jia, Y., Xu, J., Cheng, X., & Xu, C. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3043-5 · Cited by 33

Relationship between pretreatment concentration of plasma Epstein‐Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation

Peng, L., Yang, Y. J., Guo, R., Mao, Y., Xu, C., Chen, Y., Sun, Y. H., Ma, J., & Tang, L. (2018) · Cancer Medicine · doi:10.1002/cam4.1858 · Cited by 33

A comprehensive overview of liquid biopsy applications in pediatric solid tumors

Janssen, F. W., Lak, N. S. M., Janda, C. Y., Kester, L. A., Meister, M. T., Merks, J. H. M., van den Heuvel-Eibrink, M. M., van Noesel, M. M., Zsiros, J., Tytgat, G. A. M., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00657-z · Cited by 32

Extrachromosomal DNA (ecDNA) in cancer: mechanisms, functions, and clinical implications

Dong, Y., He, Q., Chen, X., Yang, F., He, L., & Zheng, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1194405 · Cited by 36

Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA

Chen, J. H., Addanki, S., Roy, D., Bassett, R. L., Kalashnikova, E. V., Spickard, E. A., Kuerer, H. M., Meas, S., Sarli, V. N., Korkut, A., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-12689-6 · Cited by 32

Mining nucleic acid “omics” to boost liquid biopsy in cancer

Tivey, A., Lee, R. J., Clipson, A., Hill, S. M., Lorigan, P. C., Rothwell, D. G., Dive, C., & Mouliere, F. C. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101736 · Cited by 34

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs

Allen, J. E., Saroya, B. S., Kunkel, M., Dicker, D. T., Das, A., Peters, K. L., Joudeh, J., Zhu, J., & El‐Deiry, W. S. (2013) · Oncotarget · doi:10.18632/oncotarget.1524 · Cited by 32

Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR

Iwama, E., Takayama, K., Harada, T., Okamoto, I., Ookubo, F., Kishimoto, J., Baba, E., Oda, Y., & Nakanishi, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4058 · Cited by 32

The '–omics' revolution and oesophageal adenocarcinoma

Weaver, J. M. J., Ross-Innes, C. S., & Fitzgerald, R. C. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.150 · Cited by 34

Analysis of tumor-derived DNA in plasma and bone marrow fluid in lung cancer patients

Goto, T., Hirotsu, Y., Oyama, T., Amemiya, K., & Omata, M. (2016) · Medical Oncology · doi:10.1007/s12032-016-0744-x · Cited by 33

The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC

Yang, Y., Shen, X., Li, R., Shen, J., Zhang, H., Yu, L., Liu, B., & Wang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.17937 · Cited by 31

ERASE-Seq: Leveraging replicate measurements to enhance ultralow frequency variant detection in NGS data

Kamps‐Hughes, N., McUsic, A., Kurihara, L. J., Harkins, T. T., Pal, P., Ray, C., & Ionescu‐Zanetti, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195272 · Cited by 32

Liquid biopsy to monitor melanoma patients

Gaiser, M. R., von Bubnoff, N. C. C., Gebhardt, C., & Utikal, J. S. (2018) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.13461 · Cited by 34

Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer

Medford, A. J., Dubash, T. D., Juric, D., Spring, L. M., Niemierko, A., Vidula, N., Peppercorn, J. M., Isakoff, S. J., Reeves, B. A., LiCausi, J. A., et al. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0090-5 · Cited by 32

Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA

Dudley, J. C., & Diehn, M. (2020) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032604 · Cited by 31

Nanopore Identification of Single Nucleotide Mutations in Circulating Tumor DNA by Multiplexed Ligation

Burck, N., Gilboa, T., Gadi, A., Nehrer, M. P., Schneider, R. J., & Meller, A. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa328 · Cited by 32

DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies

Gonçalves, E., Gonçalves-Reis, M., Pereira‐Leal, J. B., & Cardoso, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-15058-0 · Cited by 32

Circulating free DNA in the management of breast cancer.

Shaw, J., & Stebbing, J. (2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2013.06.06 · Cited by 34

Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer

Yokoi, K., Yamashita, K., & Watanabe, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040735 · Cited by 32

Assessment of Circulating Tumor Cells as a Predictive Biomarker of Histology in Women With Suspected Ovarian Cancer

Lou, E., Vogel, R. I., Teoh, D. G. K., Hoostal, S., Grad, A., Gerber, M., Monu, M. S., Łukaszewski, T., Deshpande, J., Linden, M. A., et al. (2017) · Laboratory Medicine · doi:10.1093/labmed/lmx084 · Cited by 32

Monitor tumor burden with circulating tumor DNA

Figg, W. D., & Reid, J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25361 · Cited by 21

Monitoring of Metastatic Breast Cancer Using Circulating Tumour DNA: A Comparison With Circulating Tumour Cells

Dawson, S., Tsui, D. W. Y., Murtaza, M., Biggs, H., Chin, S., Gale, D. G., Forshew, T., Wallis, M., Rosenfeld, N., & Caldas, C. (2012) · Annals of Oncology · doi:10.1016/s0923-7534(20)32772-1 · Cited by 1

Circulating tumour DNA the better of the blood biomarkers

Kirk, R. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.48 · Cited by 1

Abstract 504: Circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) are superior to CA 15-3 in predicting tumor burden, patients response to treatment and overall survival (OS) rates in metastatic breast cancer patients from Egypt

Zekri, A. N., & Bahnassy, A. A. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-504 · Cited by 1

Circulating Tumor DNA Is a Biomarker of Metastatic Breast Cancer

(2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2013-063